StockData
BioAge Labs, Inc. logo

BioAge Labs, Inc. (BIOA) stock

BIOANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/30
$5.10−0.12 (-2.30%)

Close on Nov 17, 2026Market cap $234.07MP/E –Yield –

BioAge Labs price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

BioAge Labs's price to sales ratio was 25.9× on Nov 11, 2026, against 57.5× a year earlier.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202625.9×−54.2
2025Dec 31, 202580.2×–

More BioAge Labs figures

See a number that looks wrong?